Explore the latest colorectal cancer treatment advances, from precision oncology and immunotherapy to ADCs, bispecifics, and T-cell engagers.

The first cell rejuvenation therapy is set to enter clinics, testing if aging cells can be reset to a younger, healthier ...

Meet 5 hot biotechs in Arizona, from Phoenix to Tucson, that have raised significant funding over the past decade.

Learn about Carbios' story, as the French biotech focused on recycling polyethylene terephthalate (PET), faces pressure after ...

The companies Vaxcyte, Generate Biomedicines, and Immunic bagged the biggest biotech funding rounds overall in February 2026.

February 2026 saw a major biopharma acquisition, four key buyouts, and licensing deals in antibodies, small molecules, and ...

Delve into the field of pulmonary hypertension as GSK places a $950M bet on 35Pharma's candidate HS235 following the footsteps of Winrevair.

Rare Disease Day is held on the last day of February to raise awareness for rare diseases and address drug development challenges.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

The global market share of biologics was estimated at $400 billion in 2024 and is expected to reach over $650 billion by 2030. At this rate, the global market size of biologics could even outpace that ...

Vaccines have been globally regarded as the pillar of infectious disease control and prevention. From development to their approval can take several years. Now, the FDA, the U.S. regulator overseeing ...